CCL2 and kidney cancer: Here, we found that, in HEK293 kidney cancer cells, TGR5-transfected cells with the ligand treatment suppressed gene expression of IL-1α, IL-1β, IP-10, and MCP-1 induced by TNF-α or p65 overexpression (Figure 4A, 4B).